Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Witnesses tell Assembly that digital pathology and AI could expand rural access — but cost and reimbursement block adoption
Summary
A Leica/diagnostics representative told the Assembly select committee that digitizing pathology slides and applying FDA‑cleared AI tools can speed diagnoses and reduce rural disparities, but infrastructure costs and lack of reimbursement keep U.S. adoption below 5%.
Rob Monroe, vice president and chief medical officer (diagnostics), told the Assembly Select Committee on Biotechnology and Medical Technology that digital pathology — the process of scanning traditional glass slides so pathologists can review them digitally — has the potential to improve diagnostic accuracy, speed turnaround times and reduce rural disparities in cancer…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
